[从危机到肺纤维化 - - 随着时间的推移系统性硬化症]
Kai Martin Jahns1, Matthias Dreher1,2, Konstantinos Triantafyllias3
1I Medizinische Klinik Schwerpunkt Rheumatologie und klinische Immunologie, Universitätsmedizin Mainz, Mainz, Deutschland.
Deutsche medizinische Wochenschrift (1946)
|August 5, 2025
概括
系统性硬化症 (SSc) 肺纤维化是导致死亡的主要原因. 早期使用mycophenolate mofetil (MMF) 和nintedanib的联合治疗为SSc相关的间歇性肺病提供了最佳的预后.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,其特征是广泛的纤维化.
- 从历史上看,危机是SSc的主要并发症,但改善的管理已经改变了死亡原因.
- 肺部干扰,包括间歇性肺病 (ILD) 和肺动脉高血压,现在是SSc患者的主要死亡原因.
研究的目的:
- 突出早期发现和治疗SSc中的ILD的关键重要性.
- 评估SSc.肺部表现的治疗策略.
- 评估SSc相关的渐进性肺纤维化组合治疗的疗效.
主要方法:
- 审查有关SSc管理和肺部并发症的当前文献.
- 在SSc肺病中分析mycophenolate mofetil (MMF) 的治疗结果.
- 评估宁泰达尼布在治疗SSc相关的渐进性肺纤维化中的作用.
主要成果:
- 菌酸莫菲蒂尔 (MMF) 证明在管理SSc.肺部表现方面具有有效性.
- 丁丁达尼布是德国唯一批准用于SSc相关的渐进性肺纤维化治疗的药物.
- 早期的MMF和nintedanib联合治疗显示出最显著的预后改善.
结论:
- 通过HR-CT查在SSc中早期发现ILD至关重要.
- 用MMF和nintedanib进行组合治疗是改善SSc-ILD结果的有希望的策略.
- 优化肺部并发症的治疗对于提高系统性硬化症的存活率至关重要.
相关概念视频
01:24Chronic Kidney Disease II: Clinical Manifestations
93
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
93
01:23Rheumatic Heart Disease I: Introduction
40
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
40
01:24Nephrotic Syndrome III : Nursing Management
44
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
44
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:24Nephrotic Syndrome I : Introduction
28
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
28
01:29Acute Kidney Injury III: Clinical Manifestations
94
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94